Clinical researchers from the US, Canada and the Netherlands, have reported a study to recommend clinical trial designs and outcomes for XLRP (X-linked retinitis pigmentosa). … Read More »Clinical trial development and trial outcome measures have published recommendations for XLRP studies.
Principal investigators Dr. Aaron Nagiel, MD, PhD, at Children’s Hospital of Los Angeles, and Dr. Lesley Everett, MD, PhD, MPhil, at the Oregon Health Sciences… Read More »Clinical researchers on X-linked retinoschisis (XLRS) reports the dosing of a first patient in a phase 1 / 2 study.
FDA approval of visual gains and safety of aflibercept (8mg) were announced on August 18th, indicated for the treatment of patients with wet age-related macular… Read More »Aflibercept (8mg) has been approved for wet AMD, diabetic macular edema (DME) and diabetic retinopathy (DR).
Results of a biosimilar agent (SB15) of aflibercept (Eylea) have reported comparable outcomes between the generic version and the reference drug (aflibercept) for naïve neovascular… Read More »A biosimilar of aflibercept (“SB15”) indicates comparability to the reference drug for neovascular AMD.
Researchers at Schulich School of Medicine and Dentistry, Western University, Ontario, Canada, reported a meta-analysis among AMD patients finding reduced incomes and reduced employment following… Read More »Research on AMD patients’ productivity and participation in the labour market.
Researchers at the Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Italy and the Centre of Public Health, Queen’s University… Read More »Anti-VEGF treatments for diabetic macula oedema (DMO) reports Cochrane review meta-analysis.
Researchers at the Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, have reported results on the prevalence of disease-causing variants in LCA-associated genes… Read More »Clinical and genetic profile of retinopathies among LCA patients in a large German cohort.
International clinical researchers at several collaborating institutes, from Pennsylvania to Istanbul, have reported results on the genetic contribution of the HLA-B/MICA genetic region to the… Read More »Genetic analysis in Behçet’s disease identifies novel loci associated with ocular and neurological involvement.
Researchers led by clinical scientists at the Department of Clinical Neurosciences, University of Oxford, UK, has reported that, previously, there have been no disease-specific instruments… Read More »Two new RP/LCA-specific instruments have reported strong evidence for psychometric validity on measures with RP/LCA adults and caregivers of children.
Researchers at the Department of Ophthalmology, Copenhagen University Hospital – Rigshospitalet-Glostrup, Denmark, has reported a long-term follow-up study on the natural history of PRPF31-related retinitis… Read More »A 36-year follow up study on retinitis pigmentosa (RP) patients with a Nordic population of RP11 / PRPF31.
